Unfolding Insights: How nanoDSF Is Reshaping Biotherapeutics Development At Johnson & Johnson

Q&A With Dr. Marius Müller of Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine is using nanoDSF™ technology to significantly improve its biotherapeutic development processes. While initially adopted for ID testing, it's now a "workhorse" for process characterization, stress testing, and quality control in both batch and continuous manufacturing. nanoDSF excels at detecting subtle differences in biologics, even at low concentrations, and provides reliable data in demanding pharma environments. It can identify issues if a sample is compromised, acting as an important quality safeguard.

In this Q&A With Dr. Marius Müller of Johnson & Johnson Innovative Medicine, we break down five key ways nanoDSF is making an impact. Read on to access these insights and learn more about the impact of nanoDSF technology.